Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:II-243-II-249
doi: 10.1161/01.CIR.0000138948.14144.d6
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kallenbach, K.
Right arrow Articles by Haverich, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kallenbach, K.
Right arrow Articles by Haverich, A.
Related Collections
Right arrow Valvular heart disease
Right arrow CV surgery: aortic and vascular disease
Right arrow CV surgery: valvular disease

(Circulation. 2004;110:II-243 – II-249.)
© 2004 American Heart Association, Inc.


Surgery for Aortic and Peripheral Vascular Disease

Evolving Strategies for Treatment of Acute Aortic Dissection Type A

Klaus Kallenbach, MD; Timm Oelze, MS; Rolf Salcher, MS; Christian Hagl, MD; Matthias Karck, MD PhD; Rainer G. Leyh, MD PhD; Axel Haverich, MD PhD

From the Hannover Medical School, Department of Thoracic and Cardiovascular Surgery, Hannover, Germany.

Correspondence to Dr. Klaus Kallenbach, Medizinische Hochschule Hannover, Klinik für Thorax-, Herz- und Gefäßchirurgie, Carl-Neuberg-Srtraße 1, D-30625 Hannover, Germany. E-mail kallenbach{at}thg.mh-hannover.de

Objective— To assess the outcome of 3 different surgical approaches for treatment of acute aortic dissection type A (AADA).

Methods and Results— Between October 1990 and October 2003, we operated on 295 patients (pts) for AADA. Follow-up was complete for 257 pts (87%). Supracommissural replacement (SCR) of the ascending aorta was applied to 145 pts, 64 pts received a composite replacement (comp), and 48 pts were treated with the aorta valve-sparing (AVS) reimplantation technique. Pts in SCR were older compared with AVS and comp (P=0.002), gender (overall 65% male, P=0.143) and presence of Marfan syndrome (overall 5%, P=0.109) were comparable. Cannulation of the aorta was performed more often in AVS (58%) than in comp (19%) or SCR (22%; P<0.001). Mean operation time, extracorporeal circulation time, and aortic cross-clamp time differ significantly between groups (P<0.001, respectively). Stay in the intensive care unit (P=0.12) and time of hospitalization (P=0.32) were comparable. Overall perioperative mortality was 24% and did not show significant differences between groups (AVS 10.4% versus comp 28% versus SCR 26%; P=0.053). Incidence of neurological complications was similar between groups (P=0.95). Mean time of follow-up was shorter for AVS (19±20 months) compared with comp (48±48 months) and SCR (46±45 months). Survival at 5 years was comparable with 89% for AVS, 85% for comp, and 80% for SCR (P=0.61). Two patients from AVS (4.1%) required reoperation for failure of the reconstructed valve. Pts in comp required less aortic reoperations than pts in SCR (comp 6.3% versus SCR 22%; P=0.005).

Conclusions— In acute aortic dissection type A, the reimplantation technique leads to results comparable to established techniques. Complete removal of diseased tissue, low incidence of reoperation, and lack of anticoagulation may favor this approach in selected patients.


Key Words: aortic dissection • valves • aorta • valve reconstruction • composite replacement